Search Results

Containing any of the words

Only of the type

A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) Drug Clinical Trial

A Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial with Open Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Patients with Primary Sjögren’s Disease Drug Clinical Trial

A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG Drug Clinical Trial

Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies Drug Clinical Trial

SFDA Rejects AI-Powered Diabetes Prediction Device for Failing Safety and Efficacy Standards News

Recalled products from ASTRIXPHARMA INDUSTRIAL FACTORY Drugs Circulars and withdrawal

SFDA Participated in the International Kidney Diseases Conference 2011, in Jubail News

الهيئة العامة للغذاء والدواء تواصل عملها خلال إجازة عيد الأضحى المبارك News

الهيئة العامة للغذاء والدواء تعقد ورشة عمل إطلاق مشروع المسح الميداني الشامل للمنشآت الصحية في المملكة بهدف تقييم الوضع الحالي لإعادة معالجة واستخدام الأجهزة والمنتجات الطبية ذات الاستخدام الواحد في المنشآت الصحية في المملكة News

(WU2528) NCMDR Weekly Update Medical Report